460 related articles for article (PubMed ID: 25192910)
1. TRPM7 channels regulate glioma stem cell through STAT3 and Notch signaling pathways.
Liu M; Inoue K; Leng T; Guo S; Xiong ZG
Cell Signal; 2014 Dec; 26(12):2773-81. PubMed ID: 25192910
[TBL] [Abstract][Full Text] [Related]
2. Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway.
Garner JM; Fan M; Yang CH; Du Z; Sims M; Davidoff AM; Pfeffer LM
J Biol Chem; 2013 Sep; 288(36):26167-26176. PubMed ID: 23902772
[TBL] [Abstract][Full Text] [Related]
3. TRPM7 transactivates the FOSL1 gene through STAT3 and enhances glioma stemness.
Guo S; Ramar V; Guo AA; Saafir T; Akpobiyeri H; Hudson B; Li J; Liu M
Cell Mol Life Sci; 2023 Aug; 80(9):270. PubMed ID: 37642779
[TBL] [Abstract][Full Text] [Related]
4. TRPM7 Induces Tumorigenesis and Stemness Through Notch Activation in Glioma.
Wan J; Guo AA; King P; Guo S; Saafir T; Jiang Y; Liu M
Front Pharmacol; 2020; 11():590723. PubMed ID: 33381038
[TBL] [Abstract][Full Text] [Related]
5. Suppression of TRPM7 inhibits proliferation, migration, and invasion of malignant human glioma cells.
Leng TD; Li MH; Shen JF; Liu ML; Li XB; Sun HW; Branigan D; Zeng Z; Si HF; Li J; Chen J; Xiong ZG
CNS Neurosci Ther; 2015 Mar; 21(3):252-61. PubMed ID: 25438992
[TBL] [Abstract][Full Text] [Related]
6. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion.
Chen WL; Barszczyk A; Turlova E; Deurloo M; Liu B; Yang BB; Rutka JT; Feng ZP; Sun HS
Oncotarget; 2015 Jun; 6(18):16321-40. PubMed ID: 25965832
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of TRPM7 with waixenicin A reduces glioblastoma cellular functions.
Wong R; Gong H; Alanazi R; Bondoc A; Luck A; Sabha N; Horgen FD; Fleig A; Rutka JT; Feng ZP; Sun HS
Cell Calcium; 2020 Dec; 92():102307. PubMed ID: 33080445
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma.
Lohberger B; Rinner B; Stuendl N; Absenger M; Liegl-Atzwanger B; Walzer SM; Windhager R; Leithner A
PLoS One; 2012; 7(8):e43664. PubMed ID: 22928012
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of transient receptor potential melastatin member 7 prevents migration and invasion of renal cell carcinoma cells via inactivation of the Src and Akt pathway.
Ha YS; Kim YY; Yu NH; Chun SY; Choi SH; Lee JN; Kim BS; Yoo ES; Kwon TG
Investig Clin Urol; 2018 Jul; 59(4):263-274. PubMed ID: 29984342
[TBL] [Abstract][Full Text] [Related]
12. Hypoxic Induction of Vasorin Regulates Notch1 Turnover to Maintain Glioma Stem-like Cells.
Man J; Yu X; Huang H; Zhou W; Xiang C; Huang H; Miele L; Liu Z; Bebek G; Bao S; Yu JS
Cell Stem Cell; 2018 Jan; 22(1):104-118.e6. PubMed ID: 29198941
[TBL] [Abstract][Full Text] [Related]
13. TRPM7 channel inhibition mediates midazolam-induced proliferation loss in human malignant glioma.
Chen J; Dou Y; Zheng X; Leng T; Lu X; Ouyang Y; Sun H; Xing F; Mai J; Gu J; Lu B; Yan G; Lin J; Zhu W
Tumour Biol; 2016 Nov; 37(11):14721-14731. PubMed ID: 27629139
[TBL] [Abstract][Full Text] [Related]
14. Activation of NOTCH Signaling by Tenascin-C Promotes Growth of Human Brain Tumor-Initiating Cells.
Sarkar S; Mirzaei R; Zemp FJ; Wei W; Senger DL; Robbins SM; Yong VW
Cancer Res; 2017 Jun; 77(12):3231-3243. PubMed ID: 28416488
[TBL] [Abstract][Full Text] [Related]
15. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X
J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia upregulates aldehyde dehydrogenase isoform 1 (ALDH1) expression and induces functional stem cell characteristics in human glioblastoma cells.
Soehngen E; Schaefer A; Koeritzer J; Huelsmeyer V; Zimmer C; Ringel F; Gempt J; Schlegel J
Brain Tumor Pathol; 2014 Oct; 31(4):247-56. PubMed ID: 24197864
[TBL] [Abstract][Full Text] [Related]
17. Prolactin signaling enhances colon cancer stemness by modulating Notch signaling in a Jak2-STAT3/ERK manner.
Neradugomma NK; Subramaniam D; Tawfik OW; Goffin V; Kumar TR; Jensen RA; Anant S
Carcinogenesis; 2014 Apr; 35(4):795-806. PubMed ID: 24265293
[TBL] [Abstract][Full Text] [Related]
18. A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.
Giachino C; Boulay JL; Ivanek R; Alvarado A; Tostado C; Lugert S; Tchorz J; Coban M; Mariani L; Bettler B; Lathia J; Frank S; Pfister S; Kool M; Taylor V
Cancer Cell; 2015 Dec; 28(6):730-742. PubMed ID: 26669487
[TBL] [Abstract][Full Text] [Related]
19. Suppression of TRPM7 Inhibited Hypoxia-Induced Migration and Invasion of Androgen-Independent Prostate Cancer Cells by Enhancing RACK1-Mediated Degradation of HIF-1
Yang F; Cai J; Zhan H; Situ J; Li W; Mao Y; Luo Y
Oxid Med Cell Longev; 2020; 2020():6724810. PubMed ID: 32215176
[TBL] [Abstract][Full Text] [Related]
20. Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness.
Ylivinkka I; Sihto H; Tynninen O; Hu Y; Laakso A; Kivisaari R; Laakkonen P; Keski-Oja J; Hyytiäinen M
J Exp Clin Cancer Res; 2017 Jan; 36(1):9. PubMed ID: 28069038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
